Alzheimer's drug tested on healthy volunteers – study halted early
NCT ID NCT02288000
First seen May 08, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This study aimed to see if a 15-day course of memantine, an Alzheimer's drug, could change certain brain markers in healthy young men aged 18-30. The goal was to improve early drug testing for Alzheimer's. The study was terminated early and enrolled 30 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU de Lille/ Centre d'investigation Clinique
Lille, 59037, France
-
CIC Marseille
Marseille, France
-
CIC Toulouse
Toulouse, France
Conditions
Explore the condition pages connected to this study.